Skip to main content

Featured

Number of new antibiotics has fallen sharply since 2000

Report says drugmakers need to do much more to tackle rise of superbugs

The number of new antibiotics being developed has fallen sharply since 2000 and drugmakers need to do much more to tackle the rise of superbugs, according to a report.

Britain’s biggest pharmaceutical company, GlaxoSmithKline, and US rival Johnson & Johnson are leading efforts to combat antibiotic resistance, according to the report to be presented at the World Economic Forum in Davos.

Related: The Guardian view on antibiotics: don’t keep taking the tablets | Editorial

Continue reading... January 23, 2018 at 07:31PM

Comments